Skip to main content
logo
First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
36.29
+1.83 (5.31%)
Oct 19, 2026, 2:46 PM EDT - Market open

TRAX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
168.02238.2123.0835.97
Short-Term Investments
-73.44262.29354.94
Cash & Short-Term Investments
168.02311.64385.37390.9
Cash Growth
--19.13%-1.42%-
Prepaid Expenses
-4.764.567.65
Total Current Assets
177.75316.4389.93398.56
Property, Plant & Equipment
5.413.8916.2318.27
Long-Term Investments
--35.4727.03
Other Long-Term Assets
-0.260.260.26
Total Assets
183.14330.55441.89444.11

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Accounts Payable
2.553.113.792.43
Accrued Expenses
7.4625.8330.4714.02
Current Portion of Leases
2.442.081.931.78
Total Current Liabilities
12.4531.0236.1818.22
Long-Term Leases
1.912.0314.1116.04
Total Liabilities
14.3443.0650.334.26

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Common Stock
0.04287.51391.29410.65
Comprehensive Income & Other
--0.020.31-0.8
Shareholders' Equity
168.8287.49391.6409.85
Total Liabilities & Equity
183.14330.55441.89444.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Total Debt
4.3314.1116.0417.81
Net Cash (Debt)
163.69297.53369.34373.09
Net Cash Growth
--19.44%-1.01%-
Working Capital
165.3285.38353.75380.33
Tangible Book Value
168.8287.49391.6409.85
Machinery
8.358.318.258.11
Leasehold Improvements
-0.20.20.2